Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Latest Market Insights for the Somatic Genetic Testing Industry?
In recent times, the somatic genetic testing market has witnessed a swift expansion. The market value will rise from $6.81 billion in 2024 to $7.78 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.3%. Factors contributing to the growth during the historic period include rising awareness of genetic ailments, increase in cancer cases, widespread acceptance of genetic testing in medical clinics, improved healthcare infrastructure, and a surge in patients’ demand for tailored treatment.
In the years to come, the somatic genetic testing market is projected to experience a swift growth, reaching a market size of $13.13 billion in 2029 with a compound annual growth rate (CAGR) of 14.0%. Factors contributing to this anticipated growth during the forecast period include an increased focus on early detection of diseases, a surge in collaborations between biotech and pharmaceutical firms, a rise in public-private partnerships, and enhanced accessibility of diagnostic tools. The predicted period will also see trends like advanced technology in sequencing, breakthroughs in bioinformatics and AI, investments in R&D, a surge in non-invasive test methods, and enhancements in next-generation sequencing platforms.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp
What Forces Are Driving The Growth Of The Somatic Genetic Testing Industry?
The growth of the somatic genetic testing market is set to be spurred on by the rising prevalence of cancer. Cancer, a term for a collection of diseases defined by the unrestrained growth and proliferation of abnormal cells, is becoming more common due to lifestyle factors such as poor nutrition, smoking, lack of exercise, and excessive drinking. Somatic genetic testing plays a key role in diagnosing cancer by identifying unique genetic mutations in tumors, which allows for tailored treatment options. By employing innovative technology, this form of testing reduces the need for invasive procedures and enhances the precision of diagnoses and the quality of patient outcomes. For instance, data from the Australian Institute of Health and Welfare, a government body in Australia, noted that in July 2024, the number of diagnosed cancer cases in the country had risen to 160,570 in 2022, showing an increase of 3,789 cases from 156,781 the previous year. Given these circumstances, the escalating prevalence of cancer is fuelling the expansion of the somatic genetic testing market.
What Is The Overview Of Market Segmentation In The Somatic Genetic Testing Industry?
The somatic genetic testing market covered in this report is segmented
1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Carrier Screening, Other Testing Methods
2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples
3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies
4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Inherited Genetic Disorders, Other Applications
5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, At-Home Testing Providers, Other End-Users
Subsegments:
1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels
2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing
3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing
4) By Carrier Screening: Expanded Carrier Screening, Ethnicity-Based Carrier Screening, Universal Carrier Screening
5) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing
What Future Market Trends Are Projected For The Somatic Genetic Testing Industry?
Leading firms in the somatic genetic testing sector are concentrating on developing cutting-edge diagnostic tools, like liquid biopsy tests, to enhance precision, facilitate early detection, and minimize the necessity for invasive techniques. Liquid biopsy tests are non-invasive procedures that examine circulating tumor DNA (ctDNA) or other blood sample biomarkers to identify cancer-linked genetic alterations. For example, in September 2024, Strand Life Sciences, a genomics and bioinformatics firm based in India, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-gen liquid biopsy test formulated to determine circulating tumor DNA (ctDNA) from blood specimens. The SA74-LB is a comprehensive next-gen sequencing (NGS)-based test designed to identify somatic mutations across 74 critical cancer-associated genes. This test contributes to personalized cancer therapy by pinpointing actionable mutations, tracking treatment results, and identifying minimal residual disease (MRD) without the requirement for traditional tissue biopsies. It fosters precision oncology, aiding in the direction of targeted therapies and monitoring disease progression or resistance in real-time.
Who Are The Primary Players Operating Across The Global Somatic Genetic Testing Market?
Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report
Which Region Offers The Most Growth Potential For The Somatic Genetic Testing Market Through 2029?
North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model